missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Collagen III alpha 1/COL3A1 Antibody (1E7-D7/Col3), Alexa Fluor™ 405, Novus Biologicals™
Mouse Monoclonal Antibody
Marque: Novus Biologicals NBP1-05119AF405
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Collagen III alpha 1/COL3A1 Monoclonal specifically detects Collagen III alpha 1/COL3A1 in Human, Mouse, Rat, Canine, Kangaroo, Rabbit samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.
Spécification
| Collagen III alpha 1/COL3A1 | |
| Monoclonal | |
| Alexa Fluor 405 | |
| 50mM Sodium Borate with 0.05% Sodium Azide | |
| COL3A1 | |
| This Collagen III alpha 1/COL3A1 Antibody (1E7-D7/Col3) was developed against acid-digested pepsin soluble human type III collagen | |
| Protein A purified | |
| RUO | |
| Primary | |
| Highly specific for type III collagen. It has been shown to have no cross reactivity with type I and V collagens by ELISA and immunoblotting. There is no evidence for cross-reactivity with other connective tissue proteins (laminin, fibronectin, elastin). | |
| Store at 4C in the dark. | |
| IgG1 κ |
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
| 1E7-D7/Col3 | |
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
| alpha1 (III) collagen, Collagen 3, collagen alpha-1(III) chain, collagen, fetal, collagen, type III, alpha 1, Collagen-3, EDS4A, Ehlers-Danlos syndrome type IV, autosomal dominant, FLJ34534 | |
| Mouse | |
| 139 kDa | |
| 0.1 mL | |
| Cancer, Cell Biology, Extracellular Matrix | |
| 1281 | |
| Human, Rat, Canine, Kangaroo, Rabbit | |
| Purified |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu